Extensive experimental and limited epidemiologic data suggest that adeno-associated viruses (AAV) can have antioncogenic activity and may be protective factors for the development of cervical cancer. To examine the association between AAV-2 IgG antibodies and cervical neoplasia in Spain and Colombia
Adeno-associated virus and development of cervical neoplasia
โ Scribed by Strickler, Howard D.; Viscidi, Raphael; Escoffery, Carlos; Rattray, Carole; Kotloff, Karen L.; Goldberg, Janet; Manns, Angela; Rabkin, Charles; Daniel, Richard; Hanchard, Barrie; Brown, Claudette; Hutchinson, Martha; Zanizer, David; Palefsky, Joel; Burk, Robert D.; Cranston, Beverly; Clayman, Barbara; Shah, Keerti V.
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 177 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Several gene delivery vehicles are being developed for somatic gene therapy and each of these vectors has unique properties which makes them appropriate for different human disease applications. Recombinant adenoassociated viral (rAAV) vectors are proving themselves to be safe and efยฎcacious for the
## Abstract Although the remarkable versatility and efficacy of recombinant adenoโassociated virus 2 (AAV2) vectors in transducing a wide variety of cells and tissues in vitro, and in numerous preโclinical animal models of human diseases in vivo, have been well established, the published literature